Low-dose liposomal amphotericin B effective in Kala-azar

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1303, 2001-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral miltefosine beneficial for kala-azar

By  

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Low-dose hep B vaccine effective in nonresponder neonates

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS ( R)), with commercial lipid-based formulations

By Fukui H.   Koike T.   Nakagawa T.   Saheki A.   Sonoke S.   Tomii Y.   Seki J.  

International Journal of Pharmaceutics, Vol. 267, Iss. 1, 2003-11 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Amphotericin B liposomal: Pseudohyperphosphataemia: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Amphotericin B liposomal: Liver injury: case report

By  

Reactions Weekly, Vol. 1, Iss. 1237, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite